12.5. Other financial obligations

Options received

At the time of the acquisition of Telemedi Group, an option agreement was concluded with the minority shareholder for the acquisition of the remaining 24.2 per cent with an exercise period of two or three years, under which the capital shares can be acquired in accordance with an agreed purchase price formula. However, the structure of this led to 100 per cent inclusion for the purposes of consolidated accounting and no non-controlling interests are to be recognised. Future payments resulting from the option agreement are recognised as current expenses in the exercise period in accordance with IAS/IFRS regulations – because 100 per cent have already been recognised in the consolidated financial statements. In the 2025 financial year, one of the exercisable option agreements for 7.9 per cent of the shares was exercised by the seller.

From the acquisition of Mavie Work Deutschland GmbH (Germany, Munich) in 2024, there are option agreements for the acquisition of the remaining 36.4 per cent of the company. The option agreements with the remaining shareholders, under which the capital shares can be acquired in accordance with an agreed purchase price formula, were concluded with an exercise period of two and three years, respectively. The different structure of the option agreements means that part of the resulting future payments must be treated as a purchase price component and part is recognised as a current expense in the exercise period.

In addition, there is an option agreement for the acquisition of further shares in uLékaře.cz, s.r.o (Czechia, Prague). A description of this can be found under “Scope of consolidation”.